Neutropenic Precautions: A Journey to the Development of Evidence-Based Standards

12.00
Hdl Handle:
http://hdl.handle.net/10755/165437
Category:
Abstract
Type:
Presentation
Title:
Neutropenic Precautions: A Journey to the Development of Evidence-Based Standards
Author(s):
Wivell, B.; Cramer, C.; Will, P.; Johnson, E.
Author Details:
B. Wivell, University of Colorado Health Science Center, School of Nursing, Denver, Colorado, USA; C. Cramer; P. Will; E. Johnson
Abstract:
Neutropenia is a common side effect of cancer treatment. It is the primary dose limiting toxicity of most chemotherapy regimens often resulting in neutropenic complications such as dose delays/reductions, and febrile neutropenia, which can have an overall mortality rate as high as 10%. Concern over the potential negative clinical outcomes due to neutropenic complications, the inconsistencies in nursing management of the neutropenic patient, and the lack of nursing research to guide the development of evidenced-based neutropenia standards of practice lead to the formation of the ONS Neutropenia Focus Group in 2000. The ultimate goal of this focus group is to establish a set of national evidenced-based neutropenic precaution guidelines and patient/caregiver teaching strategies. The process has at least three phases, two of which have now been completed. Phase I was a collection of information by focus group members with regard to neutropenic precautions currently utilized at various healthcare institutions. This collection of information lead to Phase II – the development of a neutropenic precautions survey. The goal of this survey was to identify the following: 1.) Neutropenic precautions utilized in inpatient/outpatient settings, if any, 2.) Patient care standards currently employed in various healthcare institutions, and 3.) Patient/caregiver teaching strategies. The survey was sent to 1500 randomly selected oncology nurses nationwide, utilizing the ONS membership database. Returned surveys will be analyzed with the intent of sharing these results at the 2003 ONS Congress in a poster abstract format. Data available for presentation will include: the most consistently utilized neutropenic precautions, associated patient care standards, and patient/caregiver educational strategies utilized in both the inpatient/outpatient settings. Analysis of the Phase II results will determine development of Phase III, including identification of nursing research opportunities to further clarify and develop evidenced-based neutropenia standards of practice.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2003
Conference Name:
28th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Denver, Colorado, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleNeutropenic Precautions: A Journey to the Development of Evidence-Based Standardsen_GB
dc.contributor.authorWivell, B.en_US
dc.contributor.authorCramer, C.en_US
dc.contributor.authorWill, P.en_US
dc.contributor.authorJohnson, E.en_US
dc.author.detailsB. Wivell, University of Colorado Health Science Center, School of Nursing, Denver, Colorado, USA; C. Cramer; P. Will; E. Johnsonen_US
dc.identifier.urihttp://hdl.handle.net/10755/165437-
dc.description.abstractNeutropenia is a common side effect of cancer treatment. It is the primary dose limiting toxicity of most chemotherapy regimens often resulting in neutropenic complications such as dose delays/reductions, and febrile neutropenia, which can have an overall mortality rate as high as 10%. Concern over the potential negative clinical outcomes due to neutropenic complications, the inconsistencies in nursing management of the neutropenic patient, and the lack of nursing research to guide the development of evidenced-based neutropenia standards of practice lead to the formation of the ONS Neutropenia Focus Group in 2000. The ultimate goal of this focus group is to establish a set of national evidenced-based neutropenic precaution guidelines and patient/caregiver teaching strategies. The process has at least three phases, two of which have now been completed. Phase I was a collection of information by focus group members with regard to neutropenic precautions currently utilized at various healthcare institutions. This collection of information lead to Phase II – the development of a neutropenic precautions survey. The goal of this survey was to identify the following: 1.) Neutropenic precautions utilized in inpatient/outpatient settings, if any, 2.) Patient care standards currently employed in various healthcare institutions, and 3.) Patient/caregiver teaching strategies. The survey was sent to 1500 randomly selected oncology nurses nationwide, utilizing the ONS membership database. Returned surveys will be analyzed with the intent of sharing these results at the 2003 ONS Congress in a poster abstract format. Data available for presentation will include: the most consistently utilized neutropenic precautions, associated patient care standards, and patient/caregiver educational strategies utilized in both the inpatient/outpatient settings. Analysis of the Phase II results will determine development of Phase III, including identification of nursing research opportunities to further clarify and develop evidenced-based neutropenia standards of practice.en_GB
dc.date.available2011-10-27T12:18:31Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:18:31Z-
dc.conference.date2003en_US
dc.conference.name28th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationDenver, Colorado, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.